Login
$COO
$61.88 -$0.77 (1.23%) Live

$COO 8-K/A SEC Filings

Filed On Filing
17 Jan 2018 8-K/A: Financial Statements and Exhibits

On November 1, 2017, CooperSurgical Inc. ("CooperSurgical"), a wholly-owned subsidiary of The Cooper Companies, Inc. (the “Company” or "TCC"), completed the acquisition (the "Acquisition") of the global rights and business (the “Acquired...

20 Oct 2014 8-K/A: Financial Statements and Exhibits

We have audited the accompanying consolidated financial statements of Sauflon Pharmaceuticals Limited (the “Company”) and its subsidiaries, which comprise the consolidated balance sheet as of October 31, 2013, and the related consolidate...

15 Nov 2007 8-K/A: Regulation FD Disclosure

This amendment is being filed to amend Exhibit 99.1of the Current Report on Form 8-K filed on November 14, 2007, to correct the presentation of United States single use contact lens growth as +25% for year to date 2007 at page 14. A copy...

15 Feb 2005 8-K/A: Completion of Acquisition or Disposition of Assets

We have audited the accompanying consolidated balance sheets of Ocular Sciences, Inc. and subsidiaries as of December 31, 2003 and 2002, and the related consolidated statements of income, stockholders’ equity and cash flows for each of t...

13 Jan 2005 8-K/A: Entry into a Material Definitive Agreement

In connection with the completion of The Cooper Companies, Inc.’s (the “Company” or “Cooper”) acquisition of Ocular Sciences, Inc (“Ocular”) on January 6, 2005, TCC Acquisition Corp., a Delaware corporation and wholly owned subsidiary of...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support